News: SSRIs treat PMS/premenstrual dysphoric disorder

Article

SSRIs effectively treat premenstrual symptoms.

Selective serotonin reuptake inhibitors (SSRIs) (i.e., citalopram, fluoxetine, paroxetine, and sertraline) effectively treat premenstrual symptoms, particularly with continuous dosing, but perhaps not as effectively as previously reported, according to the findings of a recent meta-analysis.

Researchers included 29 published double-blind, randomized controlled studies involving almost 3,000 women in their analysis.

Overall, they found SSRIs significantly effective for treating both PMS and premenstrual dysphoric disorder (OR, 0.40; 95% CI, 0.31–0.51). While no particular SSRI was more effective than another, continuous dosing regimens were more effective (OR, 0.28; 95% CI, 0.18–0.42) than intermittent ones (OR, 0.55; 95% CI, 0.45–0.68).

Shah NR, Jones JB, Aperi J, et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. Obstet Gynecol. 2008;111:1175-1182.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Thomas McElrath, MD, PhD, highlights limitations of current preeclampsia guidelines | Image Credit: physiciandirectory.brighamandwomens.org.
Jane Varney, MD, discusses how a low FODMAP diet mediates gut symptoms caused by endometriosis | Image Credit: lens.monash.edu.
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.